Delivery Order SPE2DB24D8001-SPE2DB24FKYTS
Award Date
7/17/24
Potential Completion Date
8/7/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and runs through December 31, 2025. It is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This federal contract award, identified as SPE2DB24D8001 and SPE2DB25FKZFX, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,839.89 and is structured as a Firm Fixed Price Delivery Order, with a performance period extending through March 13, 2025. Dakota Drug,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,031.98 firm fixed-price delivery order is for the provision of MENQUADFI VIAL 0.5ML medical supplies. The contract is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00 and allows the company to provide a comprehensive range of pharmaceutical...
The federal contract award SPE2DX15D8002|SPE2DX24F2TS8, valued at $2,818.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of PROQUAD VIALS, a pharmaceutical product. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract award, identified as SPE2DB24D8001, is a $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,231.24 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, with the DLA as part of the ECAT Generation V...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award, valued at $3,457.84, is a delivery order under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZDT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,528.94 and is a Firm Fixed Price Delivery Order. It is not associated with a set-aside program. Dakota...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZHD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, with a ceiling value of...